Becton, Dickinson and’s (NYSE:BDX) Buy Rating Reaffirmed at Stifel Nicolaus

Becton, Dickinson and Company (NYSE:BDX)‘s stock had its “buy” rating reaffirmed by stock analysts at Stifel Nicolaus in a report issued on Wednesday, August 9th.

A number of other research firms have also issued reports on BDX. BidaskClub lowered shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research lowered shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Thursday, May 4th. Bank of America Corporation reaffirmed a “buy” rating and set a $225.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. Raymond James Financial, Inc. raised shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and lowered their price objective for the company from $210.00 to $180.00 in a research report on Friday, June 30th. Finally, Evercore ISI raised shares of Becton, Dickinson and from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $186.00 to $200.00 in a research report on Monday, April 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $195.79.

Shares of Becton, Dickinson and (NYSE BDX) traded down 0.81% on Wednesday, reaching $197.69. 989,225 shares of the company’s stock were exchanged. The company has a market capitalization of $44.99 billion, a P/E ratio of 57.25 and a beta of 1.05. Becton, Dickinson and has a 1-year low of $161.29 and a 1-year high of $206.63. The stock’s 50-day moving average price is $199.72 and its 200-day moving average price is $188.69.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The business had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. During the same period in the previous year, the firm earned $2.35 EPS. The business’s revenue for the quarter was down 5.1% on a year-over-year basis. Analysts anticipate that Becton, Dickinson and will post $9.46 EPS for the current fiscal year.

WARNING: This piece was originally reported by Rincon Hill News and is the sole property of of Rincon Hill News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://rinconhillneighbors.org/2017/08/19/becton-dickinson-and-company-nysebdx-rating-reiterated-by-stifel-nicolaus-updated.html.

In related news, VP Jeffrey S. Sherman sold 28,765 shares of the company’s stock in a transaction on Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the completion of the transaction, the vice president now directly owns 70,821 shares in the company, valued at approximately $13,171,289.58. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Nabil Shabshab sold 6,149 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $201.76, for a total transaction of $1,240,622.24. Following the transaction, the insider now owns 15,648 shares of the company’s stock, valued at $3,157,140.48. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,631 shares of company stock valued at $11,112,178. Corporate insiders own 1.40% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America boosted its position in shares of Becton, Dickinson and by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 819 shares of the medical instruments supplier’s stock worth $150,000 after buying an additional 6 shares in the last quarter. Family Firm Inc. boosted its position in shares of Becton, Dickinson and by 0.5% in the second quarter. Family Firm Inc. now owns 1,212 shares of the medical instruments supplier’s stock worth $236,000 after buying an additional 6 shares in the last quarter. Northwest Quadrant Wealth Management LLC boosted its position in shares of Becton, Dickinson and by 0.4% in the second quarter. Northwest Quadrant Wealth Management LLC now owns 1,686 shares of the medical instruments supplier’s stock worth $332,000 after buying an additional 6 shares in the last quarter. Wellington Shields & Co. LLC boosted its position in shares of Becton, Dickinson and by 0.3% in the second quarter. Wellington Shields & Co. LLC now owns 2,541 shares of the medical instruments supplier’s stock worth $496,000 after buying an additional 7 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in shares of Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock worth $116,000 after buying an additional 9 shares in the last quarter. Hedge funds and other institutional investors own 75.57% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Analyst Recommendations for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with our FREE daily email newsletter.

 

Latest News



Leave a Reply

 
© 2006-2017 Rincon Hill News.